Thailand's Cannabis Crackdown: What's Left of the Industry

October 11, 2026

Photo via Unsplash.

Walk down Sukhumvit today and the green cannabis-leaf signs are still there, flickering above shuttered storefronts as often as open ones. Nobody in Bangkok is calling this a ban. Technically, it isn't one. Cannabis flower in Thailand has not been moved back onto the country's narcotics schedule, and officials are careful to say so whenever a journalist asks. But ask any of the thousands of shop owners and farmers who built businesses during the 2022-2024 boom, and they'll tell you the distinction feels academic. Licenses are expiring and not being renewed. New certification rules arrive with no transition period. Extract processors are being locked out of a market they helped create. The mechanism is different from a relisting, but the economic result -- closed shops, stranded investment, growers walking away from crops -- looks a great deal like prohibition by paperwork. That's the real story of Thailand's reversal: not a dramatic ban announced at a press conference, but a slow-motion regulatory squeeze, built from notifications and ministerial regulations, that's quietly doing the same damage a recriminalization law would have done, while letting the government keep a harsher option in reserve for later.

From Decriminalization to Controlled Herb

Photo by I'm Zion via Pexels.

Thailand made global headlines on June 9, 2022, when it became the first country in Asia to decriminalize cannabis, pulling the plant off the narcotics list and triggering one of the fastest retail expansions the region had ever seen. Dispensaries opened on nearly every commercial strip in Bangkok and the tourist islands, and the government itself touted cannabis as a cash crop that could diversify Thai agriculture beyond rice and rubber. That era effectively ended on June 25-26, 2025, when Public Health Minister Somsak Thepsuthin issued a notification restricting cannabis flower to medical use only. Under the new framework, buying flower requires a Thai national ID card or passport plus a PT33 prescription issued by a licensed practitioner, valid for up to 30 days. Walk-in recreational sales of bud, the backbone of the 2022-2024 retail boom, were effectively ended overnight.

The legal mechanism behind this shift is worth sitting with, because it explains why the government has more room to maneuver than a simple ban-or-no-ban framing suggests. Cannabis was not reclassified as a Category 5 narcotic. Instead, it was designated a controlled herb under the Protection and Promotion of Thai Traditional Medicine Knowledge Act B.E. 2542 (1999) -- the same law historically used to regulate herbal medicine practice. That's a meaningfully lighter legal category than narcotics scheduling, but it still gives regulators broad authority to dictate who can sell, grow, process, and prescribe cannabis, and under what conditions. It also means the Ministry of Public Health can tighten the rules repeatedly through ministerial notification rather than new legislation, which is exactly what's happened in wave after wave since mid-2025. And crucially, full relisting as a narcotic hasn't gone away as a possibility -- it remains a threat regulators can invoke if they decide the controlled-herb approach isn't restrictive enough.

The Numbers Behind the Shop Closures

As of December 28, 2025, nearly half of Thailand's 18,433 registered cannabis shop licenses (8,636) had expired, and of those only 1,339 were renewed while 7,297 shut down; still, about 11,136 shops remain operating overall.

The shop-closure data tells the story more plainly than any ministerial statement. As of December 28, 2025, Thailand had 18,433 cannabis shops registered as operating. Licenses had already expired for 8,636 of them. Of that group, only 1,339 shops -- roughly 15.5% -- managed to renew under the new conditions. The remaining 7,297 simply shut down, unable or unwilling to meet the tightened requirements, leaving 11,136 shops still running nationwide. That's a significant contraction from peak registration in the space of a single regulatory cycle, concentrated almost entirely among operators whose licenses happened to come up for renewal first.

And this is only the first wave. Thailand's licensing system staggers expiration dates, which means the pressure is going to keep arriving in predictable batches: 4,587 licenses are set to expire in 2026, with another 5,210 following in 2027. If the renewal rate holds anywhere near the 15.5% seen in the first cohort, the market could shrink by thousands more shops over the next two years without a single new law being passed. Industry watchers have started estimating the cumulative cost of these closures in the tens of millions of baht -- money sunk into retail buildouts, lease deposits, display cases, climate-controlled storage, point-of-sale systems, and staff training that can't be recovered once a shop goes dark. For an industry that was marketed to entrepreneurs as an agricultural and retail opportunity just three years ago, the attrition curve now looks less like market maturation and more like a slow bleed-out timed to license renewal dates rather than any single policy announcement.

A Shop Owner's Math Stops Working

Numbers on a spreadsheet are one thing; the math a shop owner runs on her own ledger is another. A Bangkok dispensary owner told Nation Thailand that her license expires in October 2026, and that under the new conditions, renewal simply isn't workable for a business her size. She described the capital she'd put into the shop -- buildout, inventory, staff -- as money that now feels lost, a sentiment that's become something of a common refrain among operators who expanded during the 2022-2024 boom years when the rules seemed to be heading toward permanence rather than retreat.

What's made the squeeze tighter isn't just the flower restrictions themselves, but a string of add-on requirements layered on top. Starting in January 2026, shops were required to keep a licensed medical practitioner on-site at all times -- a rule that turns a retail staffing decision into a fixed professional-wage cost that small operators have to carry whether or not customers are walking through the door. Then, on April 30, 2026, regulators imposed stricter licensing criteria specifically targeting flower sellers, raising the bar again just as some shops were trying to adjust to the on-site practitioner mandate. Each rule on its own might be survivable. Stacked together, with only months between them, they function as a cumulative cost escalation that favors whoever has the deepest pockets.

That's the pattern showing up across the industry: small, independently owned shops -- the kind opened by first-time entrepreneurs riding the initial decriminalization wave -- are the ones failing to renew. Larger chains with corporate backing, legal departments, and compliance budgets built for exactly this kind of regulatory churn are the ones still standing. It's not that bigger operators are better at the retail side of the business. It's that they can absorb a compliance cost that would sink a single-location shop in a matter of months.

Farmers Caught Without Certification

The squeeze on growers has followed a parallel track to the one hitting retail, and in some ways it's more severe because it hits earlier in the supply chain. Every cannabis farm in Thailand is now required to hold a GACP certificate -- Good Agriculture and Collection Practice -- issued by the government, confirming that cultivation meets specified quality and safety standards. Chokwan Chopaka, a prominent cannabis advocacy leader, has said that when the rules tightened, only about 100 farms nationwide actually held that certification. Given that Thailand's cannabis cultivation base had grown into the thousands of registered growers during the boom years, that's a vanishingly small share of the industry positioned to keep operating legally without scrambling.

Chopaka has warned that the testing regime attached to GACP certification is expensive enough to weed out thousands of smaller growers on cost alone, regardless of whether their cultivation practices are actually sound. The likely outcome, in her assessment, is a market that consolidates around the largest farms and corporate-backed operations -- the only players with the capital to pay for repeated lab testing, documentation, and compliance audits -- while small growers who built their livelihoods around cannabis since 2022 get priced out entirely.

Vara Thongsiri, a farmer near Bangkok, put the practical problem bluntly: the rules took effect immediately, with no transition period built in, making it functionally impossible to adapt in time. That's a recurring complaint across Thailand's cannabis sector right now -- not necessarily that the underlying safety standards are unreasonable, but that regulators have repeatedly given operators weeks rather than months to come into compliance. It's a pattern that echoes what's happened in cannabis legalization rollouts elsewhere in the world, where compliance infrastructure -- testing labs, certification bureaucracy, licensing fees -- ends up functioning as a de facto barrier that favors large capital over the small growers who were often the first to take the risk of entering the legal market.

The Extract Squeeze and a Stalled Law

Photo via Pexels.

If flower and farming make up the front end of Thailand's cannabis squeeze, extracts are where the back end is getting rewired just as aggressively. A ministerial regulation dated March 26, 2026, and effective April 26, restricted licenses for high-THC extracts to Thai juristic persons, government agencies, and the Thai Red Cross -- cutting out a wide swath of smaller processors and foreign-linked businesses that had built extraction operations during the open period. Compounding that shift, every legacy extract license in the country is set to expire on December 31, 2026, forcing a complete reset of who holds the legal right to process concentrates going forward. Operators who want to continue extracting high-THC products will need to requalify under the narrower ownership criteria from scratch.

Underlying all of this is a legislative vacuum that nobody expects to close soon. A comprehensive Cannabis and Hemp Act -- the law that was always supposed to replace the current patchwork of ministerial notifications with a stable statutory framework -- has been stuck in process for well over a year. A draft went to public consultation between April 22 and May 21, 2026, and has cleared only a first reading in the legislature, missing the mid-year session entirely. Then, in July 2026, a rival bill with stricter provisions was filed, effectively splitting legislative attention and pushing any realistic timeline for a comprehensive law out to early 2027 at the soonest.

As of October 2026, the legal status of cannabis in Thailand is still technically what it was after the June 2025 notification: off the narcotics list, but tightly bound as a controlled herb, with relisting as a narcotic remaining an unexercised but openly discussed option that regulators have not taken off the table. For an industry built on three-to-five-year investment horizons, that's not a resolved question. It's a suspended one.

What's easy to miss in the month-by-month policy coverage is that the uncertainty itself has become the economic weapon, whether or not that's anyone's deliberate intent. A business can plan around a bad rule if it knows the rule is permanent. It can even plan around a good rule with a hard compliance deadline, if the deadline gives it time to adapt. What Thai cannabis operators have faced since mid-2025 is neither: a sequence of notifications and ministerial regulations arriving every few months, each with its own short fuse, against the backdrop of a comprehensive law that keeps slipping further into the future and a rival bill promising to make things stricter still.

That's a harder environment to survive than an outright ban, in some respects, because a ban at least lets people exit cleanly and redeploy their capital elsewhere. Thailand's farmers and shop owners are instead stuck in a holding pattern -- paying rent on buildouts they can't fully use, holding licenses they're not sure they can renew, watching GACP certification and extract-licensing rules reshape who gets to stay in business faster than they can respond. Until a comprehensive Cannabis and Hemp Act actually passes, with rules stable enough to plan a planting season or a lease renewal around, the industry's real enemy isn't recriminalization. It's the fact that nobody, including the regulators writing the rules, seems to know yet what the finished version of this policy is going to look like.